stock.name

Immucell Corp.

ICCC

Market Cap$39.43M
Close$

Compare Immucell

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Immucell Corp.Immucell Corp.-6.30%-24%2.60.5
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$6.64

Current Fair Value

25.8% upside

Undervalued by 25.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$39.43 Million
Enterprise Value$49.76 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.81
Beta0.0
Outstanding Shares7,746,864
Avg 30 Day Volume6,355

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-6.26
PEG-14.38
Price to Sales2.64
Price to Book Ratio1.76
Enterprise Value to Revenue3.06
Enterprise Value to EBIT-7.8
Enterprise Value to Net Income-8
Total Debt to Enterprise0.25
Debt to Equity0.47

Revenue Sources

No data

ESG Score

No data

About Immucell Corp.

CEO: Michael Brigham